IRCT20240117060713N1招募中2 期
Evaluation of the effect of sacubitril valsartan on lv remodeling In patients with ischemic heart failure by 2D volumetry assessment
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 92
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Consent to participate in the study
- •Heart failure patients with LVEF less than 40
- •Coronary Artery Disease
- •History of angioplasty
- •Coronary artery bypass surgery
排除标准
- •Insulin-dependent diabetes mellitus
- •respiratory diseases
- •Chronic kidney diseases
- •Uncontrolled blood pressure
研究者
相似试验
招募中
不适用
Verification of the effect of sacubitril valsartan sodium hydrate on the residual renal function of peritoneal dialysis patientsEnd-stage renal failureJPRN-UMIN000048227International University of Health and Welfare45
进行中（未招募）
1 期
Studying the effect of medication (sacubitril/valsartan) on heart muscle damage after heart attacksAsymptomatic (New York Heart Association =2) left ventricular systolic dysfunction (defined as ejection fraction =40% measured by Simpson's biplane using transthoracic echocardiography) at least 3 months post myocardial infarctionMedDRA version: 20.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.1Level: LLTClassification code 10064079Term: Heart failure NYHA class ISystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10069501Term: Left ventricular systolic dysfunctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10000891Term: Acute myocardial infarctionSystem Organ Class: 10007541 - Cardiac disordersEUCTR2017-003460-13-GBHS Greater Glasgow and Clyde100
尚未招募
不适用
To study the effect of the drug Sacubutril-Valsartan on diastolic function in heart failure patientsCTRI/2020/04/024445Kasturba Medical College Manipal Academy of Higher Education Manipal
已完成
不适用
Effect of sacubitril/valsartan versus valsartan on blood pressure in hypertensive patients with chronic heart failure and chronic kidney disease, a parallel-group randomized controlled trialHypertension with chronic heart failure and chronic kidney diseaseJPRN-UMIN000043657Yokohama City University Medical Center62
招募中
4 期
To assess the effectiveness and safety of adding sacubitril/valsartan to the standard treatment for the heart failure patientsCTRI/2023/07/055325Pt B.D. Sharma UHS Rohtak